Full Coverage

Management Of Superficial Bladder Tumors

medicalnewstoday.com
Apr 6, 2008
        
Story Timeline:  231 days

UroToday.com - An Italian study group presented data on the optimal schedule regimen and the role of maintenance intravesical chemotherapy or BCG immunotherapy after transurethral resection (TUR for non muscle-invasive transitional cell cancer of the bladder (NMI TCCB) for patients at... [read full story]                    

Add Comment
Latest article on this story:

Management Of Superficial Bladder Tumors: Does Photo Dynamic TURB Improve Outcome Of Initial T1...

 medicalnewstoday.com Apr 6, 2008
First article on this story:

Management Of Superficial Bladder Tumors: Celecoxib For The Treatment Of Non-Muscle Invasive Bladder

 medicalnewstoday.com Apr 6, 2008
Selected publications with coverage of this story:
medicalnewstoday.com
RELATED
Found 2 documents:

Management Of Superficial Bladder Tumors: Does Photo Dynamic TURB Improve Outcome Of Initial T1...

medicalnewstoday.com
Apr 6, 2008
        

UroToday.com - Long-term Follow-up of a Randomized StudyStudies have shown that 5-aminolevulinic acid (5-ALA) induced fluorescence cystoscopy improves the detection of superficial bladder cancer. The results suggest a reduced rate of recurrent tumors with the use of 5-ALA fluorescence technique...

Management Of Superficial Bladder Tumors: Celecoxib For The Treatment Of Non-Muscle Invasive Bladder

medicalnewstoday.com
Apr 6, 2008
        

UroToday.com - Cyclooxygenase-2 (Cox-2) expression increases with bladder cancer tumor grade and stage. Dr. ... UroToday.com - Dr. Pagliarulo presented preliminary results from a clinical trial to evaluate the safety and efficacy of the selective inhibitor of Cox-2,...